{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:55:27Z","timestamp":1792814127620,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Siriraj Research Development Fund","award":["R2R 209\/12"],"award-info":[{"award-number":["R2R 209\/12"]}]},{"name":"Siriraj Research Development Fund","award":["R2R 209\/12"],"award-info":[{"award-number":["R2R 209\/12"]}]},{"name":"Siriraj Research Development Fund","award":["R2R 209\/12"],"award-info":[{"award-number":["R2R 209\/12"]}]},{"name":"Siriraj Research Development Fund","award":["R2R 209\/12"],"award-info":[{"award-number":["R2R 209\/12"]}]},{"name":"Siriraj Research Development Fund","award":["R2R 209\/12"],"award-info":[{"award-number":["R2R 209\/12"]}]},{"name":"Siriraj Research Development Fund","award":["R2R 209\/12"],"award-info":[{"award-number":["R2R 209\/12"]}]},{"name":"Siriraj Research Development Fund","award":["R2R 209\/12"],"award-info":[{"award-number":["R2R 209\/12"]}]},{"name":"Siriraj Research Development Fund","award":["R2R 209\/12"],"award-info":[{"award-number":["R2R 209\/12"]}]},{"name":"Siriraj Research Development Fund","award":["R2R 209\/12"],"award-info":[{"award-number":["R2R 209\/12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A prospective randomized control trial of 140 eyes from 140 patients, who underwent phacoemulsification, was conducted to compare the efficacy of subtenon corticosteroids injection with corticosteroids eye drops for controlling postoperative intraocular inflammation. Seventy patients received subtenon 20-mg triamcinolone injection (TA group), whereas the other 70 patients received 0.1% dexamethasone eye drops (Dexa group) after the uneventful surgeries. We examined and measured anterior chamber inflammation (ACI) score, laser flare-cell metering, conjunctival redness, pain, discomfort, visual acuity, intraocular pressure, and central foveal thickness on 1, 7, 14, 28 and 90\u00a0days postoperatively. At one month after the surgery, full recovery (zero ACI score) was found in 43 patients (63.20%) in the Dexa group versus 47 patients (68.10%) in the TA group (<jats:italic>p<\/jats:italic>\u2009=\u20090.55). There were no statistically significant differences in aqueous cells (<jats:italic>p<\/jats:italic>\u2009=\u20090.37) and flare (<jats:italic>p<\/jats:italic>\u2009=\u20090.86) between the two groups at one month. All participants experienced no serious adverse events. In conclusion, we found no statistically significant difference between subtenon 20-mg triamcinolone injection and 0.1% dexamethasone eye drop to control inflammation postoperatively. A single subtenon 20-mg triamcinolone injection could be an alternative anti-inflammatory treatment for an uneventful phacoemulsification.<\/jats:p>","DOI":"10.1038\/s41598-022-20522-y","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T10:02:26Z","timestamp":1664618546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of subtenon 20-mg triamcinolone injection versus 0.1% dexamethasone eye drops for controlling inflammation after phacoemulsification: a randomized controlled trial"],"prefix":"10.1038","volume":"12","author":[{"given":"Pitipol","family":"Choopong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuttacha","family":"Taetrongchit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutasinee","family":"Boonsopon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atchariya","family":"Nimkarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanyapak","family":"Srisukkosalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratuangsri","family":"Chonpimai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waree","family":"Nujoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krissana","family":"Maneephagaphun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noppakhun","family":"Panyayingyong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattaporn","family":"Tesavibul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"key":"20522_CR1","first-page":"58","volume":"113","author":"G Davis","year":"2016","unstructured":"Davis, G. The evolution of cataract surgery. MO Med 113, 58\u201362 (2016).","journal-title":"MO Med"},{"key":"20522_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jcjo.2013.09.013","volume":"49","author":"N Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez, N. et al. Factors affecting cataract surgery complications and their effect on the postoperative outcome. Can J Ophthalmol 49, 72\u201379. https:\/\/doi.org\/10.1016\/j.jcjo.2013.09.013 (2014).","journal-title":"Can J Ophthalmol"},{"key":"20522_CR3","first-page":"570","volume":"19","author":"M Waseem","year":"2009","unstructured":"Waseem, M. & Humayun, S. Comparison of anti-inflammatory activity of dexamethasone and diclofenac sodium eye drops in phacoemulsification. J Coll Phys Surg Pak 19, 570\u2013574 (2009).","journal-title":"J Coll Phys Surg Pak"},{"key":"20522_CR4","unstructured":"Simaroj, P., Sinsawad, P. & Lekhanont, K. Effects of intracameral triamcinolone and gentamicin injections following cataract surgery. J Med Assoc Thailand = Chotmaihet thangphaet 94, 819\u2013825 (2011)."},{"key":"20522_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-0420.2007.01114.x","volume":"86","author":"A Karalezli","year":"2008","unstructured":"Karalezli, A., Borazan, M. & Akova, Y. A. Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. Acta Ophthalmol 86, 183\u2013187. https:\/\/doi.org\/10.1111\/j.1600-0420.2007.01114.x (2008).","journal-title":"Acta Ophthalmol"},{"key":"20522_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3109\/09273948.2010.486098","volume":"18","author":"AA Alkawas","year":"2010","unstructured":"Alkawas, A. A., Hamdy, A. M. & Shahien, E. A. Intraoperative intravitreal injection of triamcinolone acetonide for cataract extraction in patients with uveitis. Ocul Immunol Inflamm 18, 402\u2013407. https:\/\/doi.org\/10.3109\/09273948.2010.486098 (2010).","journal-title":"Ocul Immunol Inflamm"},{"key":"20522_CR7","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.jcrs.2007.04.029","volume":"33","author":"T Dada","year":"2007","unstructured":"Dada, T., Dhawan, M., Garg, S., Nair, S. & Mandal, S. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract. J Cataract Refract Surg 33, 1613\u20131618. https:\/\/doi.org\/10.1016\/j.jcrs.2007.04.029 (2007).","journal-title":"J Cataract Refract Surg"},{"key":"20522_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12886-018-0939-3","volume":"18","author":"CY Park","year":"2018","unstructured":"Park, C. Y., Lee, J. K. & Chuck, R. S. Toxic anterior segment syndrome: an updated review. BMC Ophthalmol. 18, 276. https:\/\/doi.org\/10.1186\/s12886-018-0939-3 (2018).","journal-title":"BMC Ophthalmol."},{"key":"20522_CR9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/sj.eye.6702357","volume":"21","author":"JY Oh","year":"2007","unstructured":"Oh, J. Y., Wee, W. R., Lee, J. H. & Kim, M. K. Short-term effect of intracameral triamcinolone acetonide on corneal endothelium using the rabbit model. Eye 21, 812\u2013818. https:\/\/doi.org\/10.1038\/sj.eye.6702357 (2007).","journal-title":"Eye"},{"key":"20522_CR10","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jcrs.2005.07.023","volume":"31","author":"JP Gills","year":"2005","unstructured":"Gills, J. P. & Gills, P. Effect of intracameral triamcinolone to control inflammation following cataract surgery. J Cataract Refract Surg 31, 1670\u20131671. https:\/\/doi.org\/10.1016\/j.jcrs.2005.07.023 (2005).","journal-title":"J Cataract Refract Surg"},{"key":"20522_CR11","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1001\/archopht.121.11.1663-a","volume":"121","author":"JB Jonas","year":"2003","unstructured":"Jonas, J. B., Kreissig, I. & Degenring, R. F. Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch. Ophthalmol. 121, 1663\u20131664. https:\/\/doi.org\/10.1001\/archopht.121.11.1663-a (2003).","journal-title":"Arch. Ophthalmol."},{"key":"20522_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/jop.2008.0087","volume":"25","author":"YS Byun","year":"2009","unstructured":"Byun, Y. S. & Park, Y. H. Complications and safety profile of posterior subtenon injection of triamcinolone acetonide. J Ocul Pharmacol Ther 25, 159\u2013162. https:\/\/doi.org\/10.1089\/jop.2008.0087 (2009).","journal-title":"J Ocul Pharmacol Ther"},{"key":"20522_CR13","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1167\/iovs.08-2920","volume":"50","author":"F Paganelli","year":"2009","unstructured":"Paganelli, F. et al. A single intraoperative sub-tenon\u2019s capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. Invest Ophthalmol Vis Sci 50, 3041\u20133047. https:\/\/doi.org\/10.1167\/iovs.08-2920 (2009).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"20522_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jcrs.2005.12.102","volume":"32","author":"AK Negi","year":"2006","unstructured":"Negi, A. K., Browning, A. C. & Vernon, S. A. Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: Randomized controlled trial. J Cataract Refract Surg 32, 468\u2013474. https:\/\/doi.org\/10.1016\/j.jcrs.2005.12.102 (2006).","journal-title":"J Cataract Refract Surg"},{"key":"20522_CR15","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.ophtha.2004.04.026","volume":"111","author":"F Paganelli","year":"2004","unstructured":"Paganelli, F. et al. A single intraoperative sub-Tenon\u2019s capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Ophthalmology 111, 2102\u20132108. https:\/\/doi.org\/10.1016\/j.ophtha.2004.04.026 (2004).","journal-title":"Ophthalmology"},{"key":"20522_CR16","first-page":"1127","volume":"66","author":"H Khan","year":"2016","unstructured":"Khan, H., Alam, M. & Khan, A. Comparison of the safety and efficacy of single injection of subtenon triamcinolone and topical dexamethasone in reducing postoperative inflammation after phacoemulsification and intraocular lens implantation. J Pak Med Assoc 66, 1127\u20131131 (2016).","journal-title":"J Pak Med Assoc"},{"key":"20522_CR17","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1001\/archopht.1992.01080190066030","volume":"110","author":"A El-Maghraby","year":"1992","unstructured":"El-Maghraby, A., Marzouki, A., Matheen, T. M., Souchek, J. & Van der Karr, M. Reproducibility and validity of laser flare\/cell meter measurements as an objective method of assessing intraocular inflammation. Arch Ophthalmol 110, 960\u2013962. https:\/\/doi.org\/10.1001\/archopht.1992.01080190066030 (1992).","journal-title":"Arch Ophthalmol"},{"key":"20522_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs, D. A., Nussenblatt, R. B. & Rosenbaum, J. T. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140, 509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057 (2005).","journal-title":"Am J Ophthalmol"},{"key":"20522_CR19","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/s0886-3350(98)80170-3","volume":"24","author":"R Stewart","year":"1998","unstructured":"Stewart, R., Horwitz, B., Howes, J., Novack, G. D. & Hart, K. Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1. J Cataract Refract Surg 24, 1480\u20131489. https:\/\/doi.org\/10.1016\/s0886-3350(98)80170-3 (1998).","journal-title":"J Cataract Refract Surg"},{"key":"20522_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226118","volume":"14","author":"Y Maeda","year":"2019","unstructured":"Maeda, Y. et al. Intraocular pressure elevation after subtenon triamcinolone acetonide injection; multicentre retrospective cohort study in Japan. PLoS ONE 14, e0226118. https:\/\/doi.org\/10.1371\/journal.pone.0226118 (2019).","journal-title":"PLoS ONE"},{"key":"20522_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3129\/i07-186","volume":"43","author":"Y Yamamoto","year":"2008","unstructured":"Yamamoto, Y. et al. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection. Can J Ophthalmol 43, 42\u201347. https:\/\/doi.org\/10.3129\/i07-186 (2008).","journal-title":"Can J Ophthalmol"},{"key":"20522_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0002-9394(14)73759-6","volume":"120","author":"CJ Helm","year":"1995","unstructured":"Helm, C. J. & Holland, G. N. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 120, 55\u201364. https:\/\/doi.org\/10.1016\/s0002-9394(14)73759-6 (1995).","journal-title":"Am J Ophthalmol"},{"key":"20522_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s004170050235","volume":"237","author":"M Lafranco Dafflon","year":"1999","unstructured":"Lafranco Dafflon, M., Tran, V. T., Guex-Crosier, Y. & Herbort, C. P. Posterior sub-Tenon\u2019s steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 237, 289\u2013295. https:\/\/doi.org\/10.1007\/s004170050235 (1999).","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol."},{"key":"20522_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0002-9394(75)90280-9","volume":"80","author":"EB McLean","year":"1975","unstructured":"McLean, E. B. Inadvertent injection of corticosteroid into the choroidal vasculature. Am J Ophthalmol 80, 835\u2013837. https:\/\/doi.org\/10.1016\/0002-9394(75)90280-9 (1975).","journal-title":"Am J Ophthalmol"},{"key":"20522_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/s0002-9394(14)77728-1","volume":"85","author":"PP Ellis","year":"1978","unstructured":"Ellis, P. P. Occlusion of the central retinal artery after retrobulbar corticosteroid injection. Am J Ophthalmol 85, 352\u2013356. https:\/\/doi.org\/10.1016\/s0002-9394(14)77728-1 (1978).","journal-title":"Am J Ophthalmol"},{"key":"20522_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/0002-9394(74)90449-8","volume":"77","author":"CL Giles","year":"1974","unstructured":"Giles, C. L. Bulbar perforation during periocular injection of corticosteroids. Am J Ophthalmol 77, 438\u2013441. https:\/\/doi.org\/10.1016\/0002-9394(74)90449-8 (1974).","journal-title":"Am J Ophthalmol"},{"key":"20522_CR27","first-page":"771","volume":"17","author":"RJ Schechter","year":"1985","unstructured":"Schechter, R. J. Management of inadvertent intraocular injections. Ann Ophthalmol 17, 771\u2013775 (1985).","journal-title":"Ann Ophthalmol"},{"key":"20522_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/0002-9394(76)90072-6","volume":"82","author":"RA Nozik","year":"1976","unstructured":"Nozik, R. A. Orbital rim fat atrophy after repository periocular corticosteroid injection. Am J Ophthalmol 82, 928\u2013930. https:\/\/doi.org\/10.1016\/0002-9394(76)90072-6 (1976).","journal-title":"Am J Ophthalmol"},{"key":"20522_CR29","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/0002-9394(78)90128-9","volume":"86","author":"CG Mathias","year":"1978","unstructured":"Mathias, C. G., Maibach, H. I., Ostler, H. B., Conant, M. A. & Nelson, W. Delayed hypersensitivity to retrobulbar injections of methylprednisolone acetate. Am J Ophthalmol 86, 816\u2013819. https:\/\/doi.org\/10.1016\/0002-9394(78)90128-9 (1978).","journal-title":"Am J Ophthalmol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20522-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20522-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20522-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T20:07:57Z","timestamp":1664654877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20522-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20522"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20522-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16471"}}